Imidazole and 1,2,4-triazole derivatives with angiotensin II ant

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514382, 514397, 514307, 548250, 548252, 548253, 548254, 5483121, 546144, A61K 3141, A61K 31415, C07D25704

Patent

active

053896610

ABSTRACT:
This invention relates to novel substituted imidazole and triazole derivatives which antagonize the binding of angiotensin II to its receptors. The compounds are useful in the treatment of hypertension, heart failure, glaucoma, and hyperaldosteronism. Methods of making the compounds, novel intermediates useful in the preparation of the compounds, pharmaceutical compositions containing the compounds, and methods of using them are also covered.

REFERENCES:
patent: 4355040 (1982-10-01), Furukawa et al.
patent: 5128355 (1992-07-01), Carini et al.
patent: 5138069 (1992-08-01), Carini et al.
CA 91:206563y The indentification . . . determinations, Inglis et al., p. 271, 1979.
CA 113:23919x Imidazolidine-2,4-dione . . . antagonists, Hemmi et al., p. 663, 1990.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Imidazole and 1,2,4-triazole derivatives with angiotensin II ant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazole and 1,2,4-triazole derivatives with angiotensin II ant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole and 1,2,4-triazole derivatives with angiotensin II ant will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-288486

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.